EU Reveals Plan To Speed Development Of New COVID-19 Therapies
Project Includes A ‘Therapeutics Booster’ And R&D/Manufacturing Support
Regulatory flexibilities such as rolling review, conditional marketing authorizations and possibly an EU emergency use authorization will play a key part in the EU’s plans to identify and approve promising new coronavirus treatments.
